Blutungskomplikationen unter oraler Antikoagulation

• Literaturverzeichnis

• 1 Kirchhof P, Nabauer M, Gerth A et al. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost 2011; 105: 1010-1023
• 2 McBride D, Bruggenjurgen B, Roll S et al. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis 2007; 24: 65-72
• 3 Le Heuzey JY, Ammentorp B, Darius H et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost 2014; 111: 833-841
• 4 Mantha S, Pianka AM, Tsapatsaris N. Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic. J Thromb Thrombolysis 2011; 32: 334-342
• 5 Beyer-Westendorf JM, Werth S, Tittl L et al. Annual Meeting of the American Society of Hematology, Poster abstract 1538, Characteristics of atrial fibrillation patients not switched from VKA to NOAK and persistence on VKA – a subgroup analysis of the Prospective Dresden Noac Registry (NCT01588119). Blood Supplement 2014; 124
• 6 Heneghan C, Alonso-Coello P, Garcia-Alamino JM et al. Self-monitoring of oral anticoagulation. Lancet 2006; 367: 404-411
• 7 Weber J. Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP, eds. Side-effects of anti-inflammatory / analgesic drugs. Advances in Inflammation Research. 6. New York: Raven Press; 1984: 1-6